Loading…
The company announced the pricing of its registered direct offering.
China Pharma Holdings, Inc. (NYSE: CPHI) announced the pricing of its registered direct offering, raising $5 million. The offering was priced at market conditions and is expected to close shortly.
The company plans to use the net proceeds for general corporate purposes, including working capital and potential acquisitions. No underwriters or placement agents were involved in this offering.
As of the latest available data, China Pharma Holdings has a free float of 2,340,604 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.